載入...
Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications
Diabetes is a leading cause of cardiovascular morbidity and mortality. Despite numerous treatments for cardiovascular disease (CVD), for patients with diabetes, these therapies provide less benefit for protection from CVD. These considerations spur the concept that diabetes-specific, disease-modifyi...
Na minha lista:
| 發表在: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7992003/ https://ncbi.nlm.nih.gov/pubmed/33776930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.636267 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|